These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 17206508

  • 1. Comparative study of the efficacy of formulations containing fluconazole or paromomycin for topical treatment of infections by Leishmania (Leishmania) major and Leishmania (Leishmania) amazonensis.
    Mussi SV, Fernandes AP, Ferreira LA.
    Parasitol Res; 2007 May; 100(6):1221-6. PubMed ID: 17206508
    [Abstract] [Full Text] [Related]

  • 2. Combined topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) major leads to reduction in both lesion size and systemic parasite burdens.
    Aguiar MG, Silva DL, Nunan FA, Nunan EA, Fernandes AP, Ferreira LA.
    J Antimicrob Chemother; 2009 Dec; 64(6):1234-40. PubMed ID: 19825819
    [Abstract] [Full Text] [Related]

  • 3. Successful topical treatment of murine cutaneous leishmaniasis with a combination of paromomycin (Aminosidine) and gentamicin.
    Grogl M, Schuster BG, Ellis WY, Berman JD.
    J Parasitol; 1999 Apr; 85(2):354-9. PubMed ID: 10219319
    [Abstract] [Full Text] [Related]

  • 4. Activity of a paromomycin hydrophilic formulation for topical treatment of infections by Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis.
    Gonçalves GS, Fernandes AP, Souza RC, Cardoso JE, de Oliveira-Silva F, Maciel FC, Rabello A, Ferreira LA.
    Acta Trop; 2005 Feb; 93(2):161-7. PubMed ID: 15652330
    [Abstract] [Full Text] [Related]

  • 5. Reductions in skin and systemic parasite burdens as a combined effect of topical paromomycin and oral miltefosine treatment of mice experimentally infected with Leishmania (Leishmania) amazonensis.
    Aguiar MG, Pereira AM, Fernandes AP, Ferreira LA.
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4699-704. PubMed ID: 20713665
    [Abstract] [Full Text] [Related]

  • 6. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice.
    Bavarsad N, Fazly Bazzaz BS, Khamesipour A, Jaafari MR.
    Acta Trop; 2012 Oct; 124(1):33-41. PubMed ID: 22750480
    [Abstract] [Full Text] [Related]

  • 7. Fluconazole for the treatment of cutaneous leishmaniasis.
    Zvulunov A, Klaus S, Vardy D.
    N Engl J Med; 2002 Aug 01; 347(5):370-1; author reply 370-1. PubMed ID: 12151480
    [No Abstract] [Full Text] [Related]

  • 8. Successful Treatment of Cutaneous Leishmaniasis with Topical Paramomycin in a Child After Treatment Failure with Systemic Fluconazole.
    Chacko A, Joseph M, Feltis T, Morris SK.
    Am J Trop Med Hyg; 2016 Oct 05; 95(4):793-794. PubMed ID: 27549634
    [Abstract] [Full Text] [Related]

  • 9. Combined suboptimal schedules of topical paromomycin, meglumine antimoniate and miltefosine to treat experimental infection caused by Leishmania (Viannia) braziliensis.
    de Morais-Teixeira E, Aguiar MG, Soares de Souza Lima B, Ferreira LA, Rabello A.
    J Antimicrob Chemother; 2015 Dec 05; 70(12):3283-90. PubMed ID: 26346991
    [Abstract] [Full Text] [Related]

  • 10. Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major.
    Shazad B, Abbaszadeh B, Khamesipour A.
    Eur J Dermatol; 2005 Dec 05; 15(2):85-7. PubMed ID: 15757817
    [Abstract] [Full Text] [Related]

  • 11. Topical paromomycin for New World cutaneous leishmaniasis.
    Sosa N, Pascale JM, Jiménez AI, Norwood JA, Kreishman-Detrick M, Weina PJ, Lawrence K, McCarthy WF, Adams RC, Scott C, Ransom J, Tang D, Grogl M.
    PLoS Negl Trop Dis; 2019 May 05; 13(5):e0007253. PubMed ID: 31048871
    [Abstract] [Full Text] [Related]

  • 12. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R.
    Acta Trop; 2004 Jul 05; 91(2):153-60. PubMed ID: 15234664
    [Abstract] [Full Text] [Related]

  • 13. Cutaneous leishmaniasis treatment.
    Minodier P, Parola P.
    Travel Med Infect Dis; 2007 May 05; 5(3):150-8. PubMed ID: 17448941
    [Abstract] [Full Text] [Related]

  • 14. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z, Nakhli A, Rassaii S.
    Int J Dermatol; 2005 Dec 05; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract] [Full Text] [Related]

  • 15. Topical 15% Paromomycin-Aquaphilic for Bolivian Leishmania braziliensis Cutaneous Leishmaniasis: A Randomized, Placebo-controlled Trial.
    Soto J, Soto P, Ajata A, Luque C, Tintaya C, Paz D, Rivero D, Berman J.
    Clin Infect Dis; 2019 Feb 15; 68(5):844-849. PubMed ID: 30260376
    [Abstract] [Full Text] [Related]

  • 16. Topical delivery and in vivo antileishmanial activity of paromomycin-loaded liposomes for treatment of cutaneous leishmaniasis.
    Carneiro G, Santos DC, Oliveira MC, Fernandes AP, Ferreira LS, Ramaldes GA, Nunan EA, Ferreira LA.
    J Liposome Res; 2010 Mar 15; 20(1):16-23. PubMed ID: 19530897
    [Abstract] [Full Text] [Related]

  • 17. Non-ulcerative cutaneous leishmaniasis in Honduras fails to respond to topical paromomycin.
    Neva FA, Ponce C, Ponce E, Kreutzer R, Modabber F, Olliaro P.
    Trans R Soc Trop Med Hyg; 1997 Mar 15; 91(4):473-5. PubMed ID: 9373659
    [Abstract] [Full Text] [Related]

  • 18. Leishmania major: in vitro and in vivo anti-leishmanial activity of paromomycin ointment (Leshcutan) combined with the immunomodulator Imiquimod.
    El-On J, Bazarsky E, Sneir R.
    Exp Parasitol; 2007 Jun 15; 116(2):156-62. PubMed ID: 17306255
    [Abstract] [Full Text] [Related]

  • 19. Combination of paromomycin plus human anti-TNF-α antibodies to control the local inflammatory response in BALB/ mice with cutaneous leishmaniasis lesions.
    Schwartz J, Moreno E, Calvo A, Blanco L, Fernández-Rubio C, Sanmartín C, Nguewa P, Irache JM, Larrea E, Espuelas S.
    J Dermatol Sci; 2018 Oct 15; 92(1):78-88. PubMed ID: 30037731
    [Abstract] [Full Text] [Related]

  • 20. [Successful topical treatment of chronic cutaneous leishmaniasis with paromomycin sulfate (15%) and methylbenzethonium chloride (12%)].
    Schallreuter KU, Lemke KR.
    Hautarzt; 1994 Nov 15; 45(11):783-6. PubMed ID: 7822205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.